![]() And we're not just stopping with scalp cooling and So, fundamentally, patients want to have control when they're going through a cancer diagnosis. ![]() We're now making it possible for patients to have an affordable solution that allows them to control their privacy and their identity when they're going through a health crisis. This is something we we truly I mean, everybody here is talking about democratizing access to health care. We're taking it therapy that really has been relegated to the major, you know, the major research institutions and bringing it to Tucson, Arizona, to Marietta, Georgia to Dubois, Pennsylvania. But what's really exciting is we're already growing this market. And in addition, over 80% of our first accounts are Greenfield accounts and actually we just got the Christ Hospital in St. We have signed a deal with McKesson that makes us the preferred provider of scalp cooling for us oncology, the largest private oncology network in the United States that touches over 30% of all cancer patients in the US. And what's very exciting for us is since we went commercial in the second half of last year, we've just had outstanding traction. Well, when you take that math about our recurring revenue from the sale of CAP systems, that leads trailing revenue over the next five years just for our first major year of scalable sales, over $16.3 million, which is a pretty great business. Our target this year is to sell total of 90 systems. So we currently are commercial on the market. And this is really key for us because we're truly taking this therapy from being what I like to refer to as the redheaded stepchild of oncology for something that finally is really profitable and scalable. And so what that means for us as cooler heads we're generating for each of these systems $180,000 over their useful life. Within the first year, our machine is profitable for infusion centers returning almost $100,000 over the useful life of the machine. Well, with Medicare reimbursement of $1,850, the portable cooling unit is paid off after the first 15 patients and since each machine should be able to treat a minimum of 30 patients a year. ![]() The machines are designed to be in service for about five years, hence the service contract for years two to five. And each patient needs their own cap system which we sell for $1,100. So our portable cooling units are sold to infusion centers at an average sale price of $11,000. So how does this work? What what how, what is this magic hope we providing. So our business model not only doesn't change patient workflows for the infusion centers, but we now actually make this therapy profitable for them. And here's the real kicker, Medicare is now reimbursing for scalp cooling. Our patented cap system is designed to have superior fit, improving overall patient outcomes. Omma is designed so that when patients are done with their chemotherapy infusion, and they have several hours of therapy left, they get up and they complete their treatment someplace else in the waiting room in the atrium, and they cafe and sometimes even at home. We last year when commercial with a product we call Alma, which is the first portable, affordable and scalable solution for scalp cooling. So patients often wind up with patchy bald spots which is just as disfiguring is going bald, which is the opportunity that we seized. ![]() In addition, the model to date has been cash pay, it's been incredibly expensive for patients between two and $8,000 out of pocket, and the systems don't fit well. It doubles the amount of time a patient is in an infusion chair, decreasing patient workflows, so it simply isn't financially feasible for most infusion centers to offer it. The challenge with this therapy is to date, it has been prohibitively expensive. It's a therapy known as scalp cooling, which is known to be safe and effective. And there is a solution for hair loss from chemotherapy. Because hair loss from chemotherapy is a massive red light to the entire world that this patient is undergoing a massive medical crisis, and it prevents them from going about their day to day life as they would prefer to. And this is a huge deal for cancer patients. This bandana represents to everybody, including him that he's sick. And he actually talks a lot about how some people look great bald, but he really isn't one of them. He's currently undergoing chemotherapy for lymphoma. This is Congressman Jamie Raskin at a congressional hearing last month. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |